12:30 – 1:30 p.m., Product Theater 1
Reduction in the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF)
Speaker: Charles J. Dow, MD, FACC, cardiologist, Harvard Medical School, Boston
Sponsored by Pfizer

12:30 – 1:30 p.m., Product Theater 2
Improving Outcomes for Hospitalized Patients with HFrEF: Looking Beyond Stabilization
Speaker: Jennifer Brown, MD
Medstar Cardiology Associates
Annapolis, MD
Sponsored by Novartis Pharmaceuticals Corp.

12:30 – 1:30 p.m., Product Theater 3
The Role of the Hospital Medicine Specialist in Managing Transitions of Care in Acute Coronary Syndrome
Speaker: John Venditto, MD, MBA, senior medical director, cardiovascular metabolic disease,
U.S. Medical Affairs – AstraZeneca
Sponsored by AstraZeneca Pharmaceuticals LP